Nopp S et al (2020) Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 4(7):1178–1191. https://doi.org/10.1002/rth2.12439

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piazza G et al (2020) Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol 76(18):2060–2072. https://doi.org/10.1016/j.jacc.2020.08.070

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang MC et al (2023) Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw Open 6(3):e232338. https://doi.org/10.1001/jamanetworkopen.2023.2338

Article  PubMed  PubMed Central  Google Scholar 

Ortel TL et al (2020) American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693–4738. https://doi.org/10.1182/bloodadvances.2020001830

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piazza G, Morrow DA (2020) Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA 324(24):2548–2549. https://doi.org/10.1001/jama.2020.23422

Article  CAS  PubMed  Google Scholar 

Jimenez S et al (2021) Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the emergency department: results of the UMC-19-S8. Eur J Emerg Med 28(3):218–226. https://doi.org/10.1097/MEJ.0000000000000783

Article  PubMed  Google Scholar 

Chen S et al (2021) DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis 51(1):33–39. https://doi.org/10.1007/s11239-020-02181-w

Article  CAS  PubMed  Google Scholar 

Li JY et al (2021) Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost 19(4):1038–1048. https://doi.org/10.1111/jth.15261

Article  CAS  PubMed  Google Scholar 

Lobbes H et al (2021) Risk factors for venous thromboembolism in severe COVID-19: A Study-Level Meta-Analysis of 21 studies. Int J Environ Res Public Health 18(24). https://doi.org/10.3390/ijerph182412944

Cuker A et al (2022) American society of hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Adv 6(17):4915–4923. https://doi.org/10.1182/bloodadvances.2022007561

Article  PubMed  PubMed Central  Google Scholar 

Cuker A et al (2022) American society of hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Adv 6(17):4975–4982. https://doi.org/10.1182/bloodadvances.2022007940

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulman S et al (2023) ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost, 2024. 22(6): pp. 1779–1797 https://doi.org/10.1016/j.jtha.2024.02.011

Stone GW et al (2023) Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19. J Am Coll Cardiol 81(18):1747–1762. https://doi.org/10.1016/j.jacc.2023.02.041

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pilia E et al (2023) The effect of heparin Full-Dose anticoagulation on survival of hospitalized, Non-critically ill COVID-19 patients: A Meta-analysis of high quality studies. Lung 201(2):135–147. https://doi.org/10.1007/s00408-023-00599-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munoz-Rivas N et al (2022) Efficacy and safety of Tinzaparin in prophylactic, intermediate and therapeutic doses in Non-Critically ill patients hospitalized with COVID-19: the PROTHROMCOVID randomized controlled trial. J Clin Med 11(19). https://doi.org/10.3390/jcm11195632

Zuily S et al (2023) Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial. EClinicalMedicine 60:102031. https://doi.org/10.1016/j.eclinm.2023.102031

Article  PubMed  PubMed Central  Google Scholar 

Kumar D et al (2022) Oral Rivaroxaban in the prophylaxis of COVID-19 induced coagulopathy. J Assoc Physicians India 70(2):11–12

PubMed  Google Scholar 

Kirkup C et al (2021) Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry. J Med Virol 93(7):4303–4318. https://doi.org/10.1002/jmv.26918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Labbe V et al (2023) Effects of Standard-Dose prophylactic, High-Dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID randomized clinical trial. JAMA Intern Med 183(6):520–531. https://doi.org/10.1001/jamainternmed.2023.0456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morici N et al (2022) Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: the X-COVID-19 randomized trial. Eur J Clin Invest 52(5):e13735. https://doi.org/10.1111/eci.13735

Article  CAS  PubMed  Google Scholar 

Bohula EA et al (2022) Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT. Circulation 146(18):1344–1356. https://doi.org/10.1161/CIRCULATIONAHA.122.061533

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scudiero F et al (2021) Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res 198:34–39. https://doi.org/10.1016/j.thromres.2020.11.017

Article  CAS  PubMed  Google Scholar 

Go AS et al (2021) COVID-19 and risk of VTE in ethnically diverse populations. Chest 160(4):1459–1470. https://doi.org/10.1016/j.chest.2021.07.025

Article  CAS  PubMed  Google Scholar 

Barnes DH et al (2021) Predictors of venous thromboembolism in patients with COVID-19 in an underserved urban population: A single tertiary center experience. Clin Respir J 15(8):885–891. https://doi.org/10.1111/crj.13377

Article  CAS  PubMed  Google Scholar 

Benito N et al (2020) Pulmonary thrombosis or embolism in a large cohort of hospitalized patients with Covid-19. Front Med (Lausanne) 7:557. https://doi.org/10.3389/fmed.2020.00557

Article  PubMed  Google Scholar 

Cohen SL et al (2021) Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients. Thromb Haemost 121(8):1043–1053. https://doi.org/10.1055/a-1366-9656

Article  PubMed  PubMed Central  Google Scholar 

Fauvel C et al (2020) Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 41(32):3058–3068. https://doi.org/10.1093/eurheartj/ehaa500

Article  CAS  PubMed  Google Scholar 

Gul MH et al (2023) Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative. Respir Res 24(1):59. https://doi.org/10.1186/s12931-023-02369-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilaloglu S et al (2020) Thrombosis in hospitalized patients with COVID-19 in a new York City health system. JAMA 324(8):799–801. https://doi.org/10.1001/jama.2020.13372

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silveira WC et al (2022) Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian registry. Intern Emerg Med 17(7):1863–1878.